Search Results 891-900 of 16377 for monoclonal antibody
Has had prior anti-cancer monoclonal antibody within 4 weeks of Study Day 1 or who has not recovered from adverse events due to agents administered >4 weeks ...
We investigated whether benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor that significantly reduces the ...
... antibody. Eastern Cooperative Oncology Group (ECOG) performance status ... monoclonal antibodies ≤ 14 days prior to registration. Patients who have ...
Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI · Muscle pain · Needle biopsy · Night sweats · No ...
Has had a prior anti-cancer monoclonal antibody within 4 weeks prior to ... Has a known history of HIV (HIV 1/2 antibodies). Has known active Hepatitis ...
History of severe allergic or anaphylactic reactions to monoclonal antibodies or known hypersensitivity to any component of the obinutuzumab infusion; ...
A Mobile Unit Overcomes the Challenges to Monoclonal Antibody Infusion for COVID-. 19 in Skilled Care Facilities. J Am Geriatr Soc 2021;69(4):868-873. 66 ...
... monoclonal antibody (mAb) and for which no other more appropriate treatment option exists; At least one bidimensionally measurable lesion; Agreement to remain ...
Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Cobimetinib may stop the growth of tumor ...
Mayo Clinic researcher, Vanda A. Lennon, M.D., Ph.D., studies antibodies and autoimmune neurological symptoms in cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.